De Lucia, S.S.; Nista, E.C.; Candelli, M.; Archilei, S.; Deutschbein, F.; Capuano, E.; Gasbarrini, A.; Franceschi, F.; Pignataro, G.
Microbiota and Pancreatic Cancer: New Therapeutic Frontiers Between Engineered Microbes, Metabolites and Non-Bacterial Components. Cancers 2025, 17, 3618.
https://doi.org/10.3390/cancers17223618
AMA Style
De Lucia SS, Nista EC, Candelli M, Archilei S, Deutschbein F, Capuano E, Gasbarrini A, Franceschi F, Pignataro G.
Microbiota and Pancreatic Cancer: New Therapeutic Frontiers Between Engineered Microbes, Metabolites and Non-Bacterial Components. Cancers. 2025; 17(22):3618.
https://doi.org/10.3390/cancers17223618
Chicago/Turabian Style
De Lucia, Sara Sofia, Enrico Celestino Nista, Marcello Candelli, Sebastiano Archilei, Franziska Deutschbein, Enrico Capuano, Antonio Gasbarrini, Francesco Franceschi, and Giulia Pignataro.
2025. "Microbiota and Pancreatic Cancer: New Therapeutic Frontiers Between Engineered Microbes, Metabolites and Non-Bacterial Components" Cancers 17, no. 22: 3618.
https://doi.org/10.3390/cancers17223618
APA Style
De Lucia, S. S., Nista, E. C., Candelli, M., Archilei, S., Deutschbein, F., Capuano, E., Gasbarrini, A., Franceschi, F., & Pignataro, G.
(2025). Microbiota and Pancreatic Cancer: New Therapeutic Frontiers Between Engineered Microbes, Metabolites and Non-Bacterial Components. Cancers, 17(22), 3618.
https://doi.org/10.3390/cancers17223618